Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1335971

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1335971

LAMEA Allergy Immunotherapy Market Size, Share & Industry Trends Analysis Report By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, and Online Pharmacy), By Treatment Type, By Allergy Type, By Country and Growth Forecast, 2023 - 2030

PUBLISHED:
PAGES: 121 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Site License)
USD 1800
PDF (Enterprisewide License)
USD 2520

Add to Cart

The Latin America, Middle East and Africa Allergy Immunotherapy Market would witness market growth of 12.9% CAGR during the forecast period (2023-2030).

Due to the rising incidence of allergies and the desire for efficient treatment alternatives, the market is predicted to rise steadily throughout this time. The development of alternative immunotherapeutic medications, such as oral drops, sublingual tablets, and other types of allergy immunotherapy, may further aid in the market's expansion. The market is anticipated to grow significantly throughout this time due to the introduction of new goods and technology. Market expansion is anticipated due to the development of cutting-edge immunotherapy therapies such as immunoglobulin E (IgE) inhibitors, biologics, and gene therapies.

The market will have significant long-term growth possibilities in the future due to the rising need for individualized and successful allergy treatments from patients, doctors, and healthcare systems. Additionally, the growing need for personalized healthcare and precision medicine will probably spur the creation of novel immunotherapy treatments customized to the needs of each patient. The main factors driving the market are the rising prevalence of different types of allergies and the introduction of innovative sublingual immunotherapies in emerging nations. The increasing prevalence of various types of allergies is one of the key factors driving the market.

Large portions of the Middle East are desert. While the summer months might be hot and humid, the winter months can see considerable drops in temperature. These climatic fluctuations have the potential to aggravate chronic respiratory disorders in sensitive patients, notably asthmatics. The Asthma Program of the Department of Health seeks to reduce visits to emergency rooms, hospitalizations, absences from work and school, and, most significantly, asthma-related fatalities. The rising asthma cases and the continues working towards its treatment will surge the usage of medicine like bronchodilators and hence boost the market growth.

The Brazil market dominated the LAMEA Allergy Immunotherapy Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $57.8 million by 2030. The Argentina market is anticipated to grow at a CAGR of 13.5% during (2023 - 2030). Additionally, The UAE market would exhibit a CAGR of 12.6% during (2023 - 2030).

Based on Distribution Channel, the market is segmented into Retail Pharmacy, Hospital Pharmacy, and Online Pharmacy. Based on Treatment Type, the market is segmented into Subcutaneous Immunotherapy (SCIT), and Sublingual Immunotherapy (SLIT) (Tablets, and Drops). Based on Allergy Type, the market is segmented into Allergic Rhinitis, Allergic Asthma, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Viatris, Inc. (Mylan N.V.), Merck KGaA, NIOX Group plc, DMS Imaging SA, Adamis Pharmaceuticals Corporation, Stallergenes Greer International AG (B-Flexion), Allergy Therapeutics plc, DBV Technologies S.A., HAL Allergy B.V. (Droege International Group AG.), LETI Pharma, S.L.U.

Scope of the Study

Market Segments covered in the Report:

By Distribution Channel

  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy

By Treatment Type

  • Subcutaneous Immunotherapy (SCIT)
  • Sublingual Immunotherapy (SLIT)
    • Tablets
    • Drops

By Allergy Type

  • Allergic Rhinitis
  • Allergic Asthma
  • Others

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

  • Viatris, Inc. (Mylan N.V.)
  • Merck KGaA
  • NIOX Group plc
  • DMS Imaging SA
  • Adamis Pharmaceuticals Corporation
  • Stallergenes Greer International AG (B-Flexion)
  • Allergy Therapeutics plc
  • DBV Technologies S.A.
  • HAL Allergy B.V. (Droege International Group AG.)
  • LETI Pharma, S.L.U.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 LAMEA Allergy Immunotherapy Market, by Distribution Channel
    • 1.4.2 LAMEA Allergy Immunotherapy Market, by Treatment Type
    • 1.4.3 LAMEA Allergy Immunotherapy Market, by Allergy Type
    • 1.4.4 LAMEA Allergy Immunotherapy Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market At a Glance

  • 2.1 Key Highlight

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints
  • 3.3 Porter's Five Forces Analysis

Chapter 4. LAMEA Allergy Immunotherapy Market by Distribution Channel

  • 4.1 LAMEA Retail Pharmacy Market by Country
  • 4.2 LAMEA Hospital Pharmacy Market by Country
  • 4.3 LAMEA Online Pharmacy Market by Country

Chapter 5. LAMEA Allergy Immunotherapy Market by Treatment Type

  • 5.1 LAMEA Subcutaneous Immunotherapy (SCIT) Market by Country
  • 5.2 LAMEA Sublingual Immunotherapy (SLIT) Market by Country
  • 5.3 LAMEA Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type
    • 5.3.1 LAMEA Tablets Market by Country
    • 5.3.2 LAMEA Drops Market by Country

Chapter 6. LAMEA Allergy Immunotherapy Market by Allergy Type

  • 6.1 LAMEA Allergic Rhinitis Market by Country
  • 6.2 LAMEA Allergic Asthma Market by Country
  • 6.3 LAMEA Others Market by Country

Chapter 7. LAMEA Allergy Immunotherapy Market by Country

  • 7.1 Brazil Allergy Immunotherapy Market
    • 7.1.1 Brazil Allergy Immunotherapy Market by Distribution Channel
    • 7.1.2 Brazil Allergy Immunotherapy Market by Treatment Type
      • 7.1.2.1 Brazil Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type
    • 7.1.3 Brazil Allergy Immunotherapy Market by Allergy Type
  • 7.2 Argentina Allergy Immunotherapy Market
    • 7.2.1 Argentina Allergy Immunotherapy Market by Distribution Channel
    • 7.2.2 Argentina Allergy Immunotherapy Market by Treatment Type
      • 7.2.2.1 Argentina Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type
    • 7.2.3 Argentina Allergy Immunotherapy Market by Allergy Type
  • 7.3 UAE Allergy Immunotherapy Market
    • 7.3.1 UAE Allergy Immunotherapy Market by Distribution Channel
    • 7.3.2 UAE Allergy Immunotherapy Market by Treatment Type
      • 7.3.2.1 UAE Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type
    • 7.3.3 UAE Allergy Immunotherapy Market by Allergy Type
  • 7.4 Saudi Arabia Allergy Immunotherapy Market
    • 7.4.1 Saudi Arabia Allergy Immunotherapy Market by Distribution Channel
    • 7.4.2 Saudi Arabia Allergy Immunotherapy Market by Treatment Type
      • 7.4.2.1 Saudi Arabia Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type
    • 7.4.3 Saudi Arabia Allergy Immunotherapy Market by Allergy Type
  • 7.5 South Africa Allergy Immunotherapy Market
    • 7.5.1 South Africa Allergy Immunotherapy Market by Distribution Channel
    • 7.5.2 South Africa Allergy Immunotherapy Market by Treatment Type
      • 7.5.2.1 South Africa Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type
    • 7.5.3 South Africa Allergy Immunotherapy Market by Allergy Type
  • 7.6 Nigeria Allergy Immunotherapy Market
    • 7.6.1 Nigeria Allergy Immunotherapy Market by Distribution Channel
    • 7.6.2 Nigeria Allergy Immunotherapy Market by Treatment Type
      • 7.6.2.1 Nigeria Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type
    • 7.6.3 Nigeria Allergy Immunotherapy Market by Allergy Type
  • 7.7 Rest of LAMEA Allergy Immunotherapy Market
    • 7.7.1 Rest of LAMEA Allergy Immunotherapy Market by Distribution Channel
    • 7.7.2 Rest of LAMEA Allergy Immunotherapy Market by Treatment Type
      • 7.7.2.1 Rest of LAMEA Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type
    • 7.7.3 Rest of LAMEA Allergy Immunotherapy Market by Allergy Type

Chapter 8. Company Profiles

  • 8.1 Viatris, Inc. (Mylan N.V.)
    • 8.1.1 Company Overview
    • 8.1.2 Financial Analysis
    • 8.1.3 Segmental Analysis
    • 8.1.4 Research & Development Expense
    • 8.1.5 SWOT Analysis
  • 8.2 Merck KGaA
    • 8.2.1 Company Overview
    • 8.2.2 Financial Analysis
    • 8.2.3 Segmental and Regional Analysis
    • 8.2.4 Research & Development Expense
    • 8.2.5 SWOT Analysis
  • 8.3 NIOX Group plc
    • 8.3.1 Company Overview
    • 8.3.2 Financial Analysis
    • 8.3.3 Segmental Analysis
    • 8.3.4 Research & Development Expenses
    • 8.3.5 SWOT Analysis
  • 8.4 DMS Imaging SA
    • 8.4.1 Company Overview
    • 8.4.2 Financial Analysis
    • 8.4.3 Regional Analysis
    • 8.4.4 SWOT Analysis
  • 8.5 Adamis Pharmaceuticals Corporation
    • 8.5.1 Company Overview
    • 8.5.2 Financial Analysis
    • 8.5.3 Research & Development Expenses
    • 8.5.4 SWOT Analysis
  • 8.6 Stallergenes Greer International AG (B-Flexion)
    • 8.6.1 Company Overview
    • 8.6.2 Recent strategies and developments:
      • 8.6.2.1 Partnerships, Collaborations, and Agreements:
      • 8.6.2.2 Acquisition and Mergers:
    • 8.6.3 SWOT Analysis
  • 8.7 Allergy Therapeutics plc
    • 8.7.1 Company Overview
    • 8.7.2 Financial Analysis
    • 8.7.3 Segmental Analysis
    • 8.7.4 Research & Development Expenses
    • 8.7.5 SWOT Analysis
  • 8.8 DBV Technologies S.A.
    • 8.8.1 Company Overview
    • 8.8.2 Financial Analysis
    • 8.8.3 Research & Development Expenses
    • 8.8.4 SWOT Analysis
  • 8.9 HAL Allergy B.V. (Droege International Group AG.)
    • 8.9.1 Company Overview
    • 8.9.2 SWOT Analysis
  • 8.10. LETI Pharma, S.L.U.
    • 8.10.1 Company Overview

LIST OF TABLES

  • TABLE 1 LAMEA Allergy Immunotherapy Market, 2019 - 2022, USD Million
  • TABLE 2 LAMEA Allergy Immunotherapy Market, 2023 - 2030, USD Million
  • TABLE 3 LAMEA Allergy Immunotherapy Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 4 LAMEA Allergy Immunotherapy Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 5 LAMEA Retail Pharmacy Market by Country, 2019 - 2022, USD Million
  • TABLE 6 LAMEA Retail Pharmacy Market by Country, 2023 - 2030, USD Million
  • TABLE 7 LAMEA Hospital Pharmacy Market by Country, 2019 - 2022, USD Million
  • TABLE 8 LAMEA Hospital Pharmacy Market by Country, 2023 - 2030, USD Million
  • TABLE 9 LAMEA Online Pharmacy Market by Country, 2019 - 2022, USD Million
  • TABLE 10 LAMEA Online Pharmacy Market by Country, 2023 - 2030, USD Million
  • TABLE 11 LAMEA Allergy Immunotherapy Market by Treatment Type, 2019 - 2022, USD Million
  • TABLE 12 LAMEA Allergy Immunotherapy Market by Treatment Type, 2023 - 2030, USD Million
  • TABLE 13 LAMEA Subcutaneous Immunotherapy (SCIT) Market by Country, 2019 - 2022, USD Million
  • TABLE 14 LAMEA Subcutaneous Immunotherapy (SCIT) Market by Country, 2023 - 2030, USD Million
  • TABLE 15 LAMEA Sublingual Immunotherapy (SLIT) Market by Country, 2019 - 2022, USD Million
  • TABLE 16 LAMEA Sublingual Immunotherapy (SLIT) Market by Country, 2023 - 2030, USD Million
  • TABLE 17 LAMEA Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2019 - 2022, USD Million
  • TABLE 18 LAMEA Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2023 - 2030, USD Million
  • TABLE 19 LAMEA Tablets Market by Country, 2019 - 2022, USD Million
  • TABLE 20 LAMEA Tablets Market by Country, 2023 - 2030, USD Million
  • TABLE 21 LAMEA Drops Market by Country, 2019 - 2022, USD Million
  • TABLE 22 LAMEA Drops Market by Country, 2023 - 2030, USD Million
  • TABLE 23 LAMEA Allergy Immunotherapy Market by Allergy Type, 2019 - 2022, USD Million
  • TABLE 24 LAMEA Allergy Immunotherapy Market by Allergy Type, 2023 - 2030, USD Million
  • TABLE 25 LAMEA Allergic Rhinitis Market by Country, 2019 - 2022, USD Million
  • TABLE 26 LAMEA Allergic Rhinitis Market by Country, 2023 - 2030, USD Million
  • TABLE 27 LAMEA Allergic Asthma Market by Country, 2019 - 2022, USD Million
  • TABLE 28 LAMEA Allergic Asthma Market by Country, 2023 - 2030, USD Million
  • TABLE 29 LAMEA Others Market by Country, 2019 - 2022, USD Million
  • TABLE 30 LAMEA Others Market by Country, 2023 - 2030, USD Million
  • TABLE 31 LAMEA Allergy Immunotherapy Market by Country, 2019 - 2022, USD Million
  • TABLE 32 LAMEA Allergy Immunotherapy Market by Country, 2023 - 2030, USD Million
  • TABLE 33 Brazil Allergy Immunotherapy Market, 2019 - 2022, USD Million
  • TABLE 34 Brazil Allergy Immunotherapy Market, 2023 - 2030, USD Million
  • TABLE 35 Brazil Allergy Immunotherapy Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 36 Brazil Allergy Immunotherapy Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 37 Brazil Allergy Immunotherapy Market by Treatment Type, 2019 - 2022, USD Million
  • TABLE 38 Brazil Allergy Immunotherapy Market by Treatment Type, 2023 - 2030, USD Million
  • TABLE 39 Brazil Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2019 - 2022, USD Million
  • TABLE 40 Brazil Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2023 - 2030, USD Million
  • TABLE 41 Brazil Allergy Immunotherapy Market by Allergy Type, 2019 - 2022, USD Million
  • TABLE 42 Brazil Allergy Immunotherapy Market by Allergy Type, 2023 - 2030, USD Million
  • TABLE 43 Argentina Allergy Immunotherapy Market, 2019 - 2022, USD Million
  • TABLE 44 Argentina Allergy Immunotherapy Market, 2023 - 2030, USD Million
  • TABLE 45 Argentina Allergy Immunotherapy Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 46 Argentina Allergy Immunotherapy Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 47 Argentina Allergy Immunotherapy Market by Treatment Type, 2019 - 2022, USD Million
  • TABLE 48 Argentina Allergy Immunotherapy Market by Treatment Type, 2023 - 2030, USD Million
  • TABLE 49 Argentina Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2019 - 2022, USD Million
  • TABLE 50 Argentina Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2023 - 2030, USD Million
  • TABLE 51 Argentina Allergy Immunotherapy Market by Allergy Type, 2019 - 2022, USD Million
  • TABLE 52 Argentina Allergy Immunotherapy Market by Allergy Type, 2023 - 2030, USD Million
  • TABLE 53 UAE Allergy Immunotherapy Market, 2019 - 2022, USD Million
  • TABLE 54 UAE Allergy Immunotherapy Market, 2023 - 2030, USD Million
  • TABLE 55 UAE Allergy Immunotherapy Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 56 UAE Allergy Immunotherapy Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 57 UAE Allergy Immunotherapy Market by Treatment Type, 2019 - 2022, USD Million
  • TABLE 58 UAE Allergy Immunotherapy Market by Treatment Type, 2023 - 2030, USD Million
  • TABLE 59 UAE Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2019 - 2022, USD Million
  • TABLE 60 UAE Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2023 - 2030, USD Million
  • TABLE 61 UAE Allergy Immunotherapy Market by Allergy Type, 2019 - 2022, USD Million
  • TABLE 62 UAE Allergy Immunotherapy Market by Allergy Type, 2023 - 2030, USD Million
  • TABLE 63 Saudi Arabia Allergy Immunotherapy Market, 2019 - 2022, USD Million
  • TABLE 64 Saudi Arabia Allergy Immunotherapy Market, 2023 - 2030, USD Million
  • TABLE 65 Saudi Arabia Allergy Immunotherapy Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 66 Saudi Arabia Allergy Immunotherapy Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 67 Saudi Arabia Allergy Immunotherapy Market by Treatment Type, 2019 - 2022, USD Million
  • TABLE 68 Saudi Arabia Allergy Immunotherapy Market by Treatment Type, 2023 - 2030, USD Million
  • TABLE 69 Saudi Arabia Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2019 - 2022, USD Million
  • TABLE 70 Saudi Arabia Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2023 - 2030, USD Million
  • TABLE 71 Saudi Arabia Allergy Immunotherapy Market by Allergy Type, 2019 - 2022, USD Million
  • TABLE 72 Saudi Arabia Allergy Immunotherapy Market by Allergy Type, 2023 - 2030, USD Million
  • TABLE 73 South Africa Allergy Immunotherapy Market, 2019 - 2022, USD Million
  • TABLE 74 South Africa Allergy Immunotherapy Market, 2023 - 2030, USD Million
  • TABLE 75 South Africa Allergy Immunotherapy Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 76 South Africa Allergy Immunotherapy Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 77 South Africa Allergy Immunotherapy Market by Treatment Type, 2019 - 2022, USD Million
  • TABLE 78 South Africa Allergy Immunotherapy Market by Treatment Type, 2023 - 2030, USD Million
  • TABLE 79 South Africa Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2019 - 2022, USD Million
  • TABLE 80 South Africa Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2023 - 2030, USD Million
  • TABLE 81 South Africa Allergy Immunotherapy Market by Allergy Type, 2019 - 2022, USD Million
  • TABLE 82 South Africa Allergy Immunotherapy Market by Allergy Type, 2023 - 2030, USD Million
  • TABLE 83 Nigeria Allergy Immunotherapy Market, 2019 - 2022, USD Million
  • TABLE 84 Nigeria Allergy Immunotherapy Market, 2023 - 2030, USD Million
  • TABLE 85 Nigeria Allergy Immunotherapy Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 86 Nigeria Allergy Immunotherapy Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 87 Nigeria Allergy Immunotherapy Market by Treatment Type, 2019 - 2022, USD Million
  • TABLE 88 Nigeria Allergy Immunotherapy Market by Treatment Type, 2023 - 2030, USD Million
  • TABLE 89 Nigeria Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2019 - 2022, USD Million
  • TABLE 90 Nigeria Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2023 - 2030, USD Million
  • TABLE 91 Nigeria Allergy Immunotherapy Market by Allergy Type, 2019 - 2022, USD Million
  • TABLE 92 Nigeria Allergy Immunotherapy Market by Allergy Type, 2023 - 2030, USD Million
  • TABLE 93 Rest of LAMEA Allergy Immunotherapy Market, 2019 - 2022, USD Million
  • TABLE 94 Rest of LAMEA Allergy Immunotherapy Market, 2023 - 2030, USD Million
  • TABLE 95 Rest of LAMEA Allergy Immunotherapy Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 96 Rest of LAMEA Allergy Immunotherapy Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 97 Rest of LAMEA Allergy Immunotherapy Market by Treatment Type, 2019 - 2022, USD Million
  • TABLE 98 Rest of LAMEA Allergy Immunotherapy Market by Treatment Type, 2023 - 2030, USD Million
  • TABLE 99 Rest of LAMEA Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2019 - 2022, USD Million
  • TABLE 100 Rest of LAMEA Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2023 - 2030, USD Million
  • TABLE 101 Rest of LAMEA Allergy Immunotherapy Market by Allergy Type, 2019 - 2022, USD Million
  • TABLE 102 Rest of LAMEA Allergy Immunotherapy Market by Allergy Type, 2023 - 2030, USD Million
  • TABLE 103 key information - Viatris, Inc.
  • TABLE 104 key Information - Merck KGaA
  • TABLE 105 Key Information - NIOX Group plc
  • TABLE 106 Key Information - DMS Imaging SA
  • TABLE 107 Key Information - Adamis Pharmaceuticals Corporation
  • TABLE 108 Key Information - Stallergenes Greer International AG
  • TABLE 109 Key Information - Allergy Therapeutics plc
  • TABLE 110 Key Information - DBV TECHNOLOGIES S.A.
  • TABLE 111 Key Information - HAL Allergy B.V.
  • TABLE 112 Key Information - LETI Pharma, S.L.U.

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 LAMEA Allergy Immunotherapy Market, 2019 - 2030, USD Million
  • FIG 3 Key Factors Impacting the Allergy Immunotherapy Market
  • FIG 4 Porter's Five Forces Analysis - Allergy Immunotherapy Market
  • FIG 5 LAMEA Allergy Immunotherapy Market share by Distribution Channel, 2022
  • FIG 6 LAMEA Allergy Immunotherapy Market share by Distribution Channel, 2030
  • FIG 7 LAMEA Allergy Immunotherapy Market by Distribution Channel, 2019 - 2030, USD Million
  • FIG 8 LAMEA Allergy Immunotherapy Market share by Treatment Type, 2022
  • FIG 9 LAMEA Allergy Immunotherapy Market share by Treatment Type, 2030
  • FIG 10 LAMEA Allergy Immunotherapy Market by Treatment Type, 2019 - 2030, USD Million
  • FIG 11 LAMEA Allergy Immunotherapy Market share by Allergy Type, 2022
  • FIG 12 LAMEA Allergy Immunotherapy Market share by Allergy Type, 2030
  • FIG 13 LAMEA Allergy Immunotherapy Market by Allergy Type, 2019 - 2030, USD Million
  • FIG 14 LAMEA Allergy Immunotherapy Market share by Country, 2022
  • FIG 15 LAMEA Allergy Immunotherapy Market share by Country, 2030
  • FIG 16 LAMEA Allergy Immunotherapy Market by Country, 2019 - 2030, USD Million
  • FIG 17 SWOT Analysis: Viatris, Inc.
  • FIG 18 Swot Analysis: Merck KGaA
  • FIG 19 SWOT Analysis: NIOX Group plc
  • FIG 20 SWOT Analysis: DMS Imaging SA
  • FIG 21 SWOT Analysis: Adamis Pharmaceuticals Corporation
  • FIG 22 Recent strategies and developments: Stallergenes Greer International AG
  • FIG 23 SWOT Analysis: Stallergenes Greer International AG
  • FIG 24 SWOT Analysis: Allergy Therapeutics plc
  • FIG 25 SWOT Analysis: DBV Technologies S.A.
  • FIG 26 SWOT Analysis: HAL Allergy B.V.
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!